Sentrimed is classified as operating in the N/A industry, NAICS Code .
Investor Activity
Sentrimed has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
March 7, 2024
1
33%
$2 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Sentrimed is developing and marketing.
Sentrimed doesn't have any recent trademark applications, indicating Sentrimed is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
SENTRIMED Active chemical ingredients for use in the manufacture of anti-cancer drugs
01/20/2017
See all trademarks and details in the Full Report.
Nearby Competitors
These companies are similar in business line and location to Sentrimed.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Sentrimed and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.